Payment overview · 2025
General Payments
$284.21
3 reported records · 3 companies
Healthcare provider profile · identity verified
Michael Yoon, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · DANVERS, MA · NPI 1790761294
Verified facts
What the public records show
CMS Open Payments records show Michael Yoon, M.D. received $284.21 in general payments during 2025 across 3 reported records.
EBI, LLC accounted for 45.5% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 3 associated products.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| EBI, LLC | Unresolved — no canonical attribution shown | $129.42 | 45.5% | 1 | 2025 |
| Highridge Medical LLC | Unresolved — no canonical attribution shown | $129.42 | 45.5% | 1 | 2025 |
| Hologic Sales and Service, LLC | Unresolved — no canonical attribution shown | $25.37 | 8.9% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $284.21 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| BIOMET SPINALPAK NON-INVASIVE SPINE FUSION STIMULATOR SYSTEM Normalized: biomet spinalpak non invasive spine fusion stimulator system |
Device | EBI, LLC, Highridge Medical LLC | $258.84 | 2 | 2025 |
Source payment records
|
|||||
| APTIMA Normalized: aptima |
Device | Hologic Sales and Service, LLC | $25.37 | 1 | 2025 |
Source payment records
|
|||||
| THINPREP 2000 PROCESSOR Normalized: thinprep 2000 processor |
Device | Hologic Sales and Service, LLC | $25.37 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
None of this doctor’s payer companies has same-entity product evidence that passes the publication threshold. The site does not infer company ownership, affiliates, or generic manufacturers.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 434 | 120 |
| Lisinopril | Lisinopril | 390 | 111 |
| Oxycodone Hcl | Oxycodone Hcl | 383 | 26 |
| Omeprazole | Omeprazole | 300 | 79 |
| Gabapentin | Gabapentin | 236 | 45 |
| Amlodipine Besylate | Amlodipine Besylate | 231 | 68 |
| Metoprolol Succinate | Metoprolol Succinate | 226 | 63 |
| Simvastatin | Simvastatin | 222 | 53 |
| Levothyroxine Sodium | Levothyroxine Sodium | 194 | 52 |
| Hydrochlorothiazide | Hydrochlorothiazide | 190 | 55 |
| Tamsulosin Hcl | Tamsulosin Hcl | 166 | 37 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 165 | 51 |
| Eliquis | Apixaban | 161 | 28 |
| Losartan Potassium | Losartan Potassium | 156 | 45 |
| Trazodone Hcl | Trazodone Hcl | 143 | 33 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 142 | 12 |
| Lorazepam | Lorazepam | 137 | 32 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 124 | 35 |
| Alprazolam | Alprazolam | 123 | 21 |
| Escitalopram Oxalate | Escitalopram Oxalate | 123 | 38 |
| Citalopram Hbr | Citalopram Hydrobromide | 115 | 25 |
| Allopurinol | Allopurinol | 110 | 28 |
| Metformin Hcl Er | Metformin Hcl | 110 | 32 |
| Metformin Hcl | Metformin Hcl | 109 | 22 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 108 | 12 |
| Pantoprazole Sodium | Pantoprazole Sodium | 107 | 32 |
| Atenolol | Atenolol | 105 | 28 |
| Sertraline Hcl | Sertraline Hcl | 103 | 25 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 100 | 18 |
| Ibuprofen | Ibuprofen | 97 | 21 |
| Furosemide | Furosemide | 95 | 22 |
| Diazepam | Diazepam | 86 | 11 |
| Metoprolol Tartrate | Metoprolol Tartrate | 85 | 22 |
| Clonazepam | Clonazepam | 81 | 15 |
| Fluticasone Propionate | Fluticasone Propionate | 75 | 29 |
| Prednisone | Prednisone | 75 | 32 |
| Tramadol Hcl | Tramadol Hcl | 73 | 12 |
| Pravastatin Sodium | Pravastatin Sodium | 62 | 14 |
| Symbicort | Budesonide/Formoterol Fumarate | 57 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 53 | suppressed |
| Oxycontin | Oxycodone Hcl | 51 | suppressed |
| Meloxicam | Meloxicam | 49 | 14 |
| Clopidogrel | Clopidogrel Bisulfate | 48 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 48 | 12 |
| Zolpidem Tartrate | Zolpidem Tartrate | 45 | suppressed |
| Baclofen | Baclofen | 44 | suppressed |
| Bupropion Xl | Bupropion Hcl | 44 | 11 |
| Warfarin Sodium | Warfarin Sodium | 44 | 12 |
| Fenofibrate | Fenofibrate | 43 | suppressed |
| Glimepiride | Glimepiride | 42 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 41 | 22 |
| Hydralazine Hcl | Hydralazine Hcl | 41 | suppressed |
| Quetiapine Fumarate | Quetiapine Fumarate | 41 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 40 | suppressed |
| Hydromorphone Hcl | Hydromorphone Hcl | 40 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 39 | 12 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 38 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 36 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 36 | suppressed |
| Spironolactone | Spironolactone | 36 | 11 |
| Ventolin Hfa | Albuterol Sulfate | 36 | suppressed |
| Jardiance | Empagliflozin | 35 | suppressed |
| Methadone Hcl | Methadone Hcl | 34 | suppressed |
| Mirtazapine | Mirtazapine | 34 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 32 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 32 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 32 | suppressed |
| Carvedilol | Carvedilol | 31 | suppressed |
| Famotidine | Famotidine | 30 | suppressed |
| Methocarbamol | Methocarbamol | 30 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 30 | 12 |
| Ondansetron Odt | Ondansetron | 29 | suppressed |
| Valsartan | Valsartan | 29 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 29 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 28 | suppressed |
| Celecoxib | Celecoxib | 27 | suppressed |
| Risperidone | Risperidone | 27 | suppressed |
| Carisoprodol | Carisoprodol | 26 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 26 | suppressed |
| Trulicity | Dulaglutide | 26 | suppressed |
| Azithromycin | Azithromycin | 25 | 22 |
| Fluconazole | Fluconazole | 25 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 25 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 24 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 23 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 23 | suppressed |
| Lamotrigine | Lamotrigine | 23 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 23 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 22 | 13 |
| Doxazosin Mesylate | Doxazosin Mesylate | 22 | suppressed |
| Dutasteride | Dutasteride | 22 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 21 | suppressed |
| Chlorthalidone | Chlorthalidone | 21 | suppressed |
| Dextroamphetamine-Amphet Er | Dextroamphetamine/Amphetamine | 21 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 21 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 21 | suppressed |
| Ozempic | Semaglutide | 20 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 20 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 20 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 20 | suppressed |
| Verapamil Er | Verapamil Hcl | 20 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 19 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 19 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 19 | 14 |
| Torsemide | Torsemide | 19 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 19 | 11 |
| Buspirone Hcl | Buspirone Hcl | 18 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 18 | suppressed |
| Ezetimibe | Ezetimibe | 18 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 18 | suppressed |
| Levetiracetam | Levetiracetam | 18 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 18 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 17 | suppressed |
| Clobazam | Clobazam | 17 | suppressed |
| Lidocaine | Lidocaine | 17 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 17 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 17 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 17 | suppressed |
| Synthroid | Levothyroxine Sodium | 17 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 17 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 17 | suppressed |
| Vascepa | Icosapent Ethyl | 17 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 16 | suppressed |
| Finasteride | Finasteride | 16 | suppressed |
| Naproxen | Naproxen | 16 | suppressed |
| Clotrimazole | Clotrimazole | 15 | suppressed |
| Colchicine | Colchicine | 15 | suppressed |
| Methylprednisolone | Methylprednisolone | 15 | 13 |
| Nystatin | Nystatin | 15 | suppressed |
| Potassium Chloride | Potassium Chloride | 15 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 15 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 14 | suppressed |
| Divalproex Sodium | Divalproex Sodium | 14 | suppressed |
| Lamotrigine Er | Lamotrigine | 14 | suppressed |
| Enulose | Lactulose | 13 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 13 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 13 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 13 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 12 | suppressed |
| Carbamazepine | Carbamazepine | 12 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 12 | suppressed |
| Hydrocortisone | Hydrocortisone | 12 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 12 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 12 | suppressed |
| Xarelto | Rivaroxaban | 12 | suppressed |
| Ativan | Lorazepam | 11 | suppressed |
| Gemfibrozil | Gemfibrozil | 11 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 11 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 11 | suppressed |
| Mupirocin | Mupirocin | 11 | suppressed |
| Nifedipine Er | Nifedipine | 11 | suppressed |
| Pulmicort Flexhaler | Budesonide | 11 | suppressed |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $284.21 · 3 records | EBI, LLC | APTIMA, BIOMET SPINALPAK NON-INVASIVE SPINE FUSION STIMULATOR SYSTEM, THINPREP 2000 PROCESSOR | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error